
Questions include how to prevent cross-contamination and how to comply with FDA’s gluten-free rules.

Questions include how to prevent cross-contamination and how to comply with FDA’s gluten-free rules.

The senators also criticized the “inconsistent” enforcement actions of the Department of Justice under Lynch’s predecessor, Eric Holder.

Tetrahedron is now seeking broad U.S. commercialization of its unique nature-identical ingredient Ergoneine.

“I personally feel bad for all the Chinese companies that are and have been producing good products,” says USCHPA's Crowther.

Companies must have a realistic understanding of the timeframes and effort involved.

Companies must have a realistic understanding of the timeframes and effort involved.

Companies must have a realistic understanding of the timeframes and effort involved.

Companies must have a realistic understanding of the timeframes and effort involved.

Companies must have a realistic understanding of the timeframes and effort involved.

The first months of 2015 have already offered the agency several possible opportunities to comment or take regulatory action on caffeine.

The move comes less than a week after FDA enforced against a different stimulant adulterant.

No transparency? Pivotal data in the case building against the dietary supplement industry is still under the NY AG's lock and key.

The New York Attorney General wants better quality assurance for dietary supplements. So does the supplements industry. So how does it get there?

GNC’s CEO Mike Archbold says industry “should embrace, not fear, novel testing methods.”

FDA has drawn criticism for failing to act despite being aware of the adulteration.

Attorney General Eric Schneiderman’s letter asks Congress to launch investigation on supplements.

Nutraceutical companies who pursue IP litigation are protecting the industry at large.

The Council for Responsible Nutrition says it is “disappointed” by the outcome: “We believe it’s a mistake.”

While global health bodies emphasize the importance of folic acid, could proposed policy changes in the United States take us a step backwards?

While not necessarily “new,” growth hormone releasing peptides could become an “issue,” said John Travis of NSF International.

The alliance could eventually include a centralized software platform that enables QA managers to manage multiple certifications.

Pending food manufacturing regulations mean manufacturers and suppliers must work together toward compliance.

Experts in DNA testing have come together in a new white paper questioning proper use in the ongoing dietary supplement investigation led by NY AG Eric Schneiderman.

Qualitas Health discusses pursuing GRAS affirmation for food and beverage use.

What's changing? Industry initiative for enhanced self-regulation of GRAS practices is likely.

FDA’s Food Safety Modernization Act: 2014 actions and 2015 deadlines

Will industry’s messaging be heard in the fight against New York Attorney General Eric Schneiderman?

Key issues facing the natural products industry in 2015, according to Nutritional Outlook’s editorial advisory board.

Krill, menhaden, and salmon oils (both farmed and wild)-which previously were excluded-will now be included in the draft standard.